Clinical trial
A Prospective Study of Dermatological Complications Associated With Continuous Subcutaneous Insulin Infusion and/or Continuous Glucose Monitoring in Pediatric Patients With Type 1 Diabetes
NCT04258904 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Dermatological Complications Associated With Continuous Subcutaneous Insulin Infusion and/or Continuous Glucose Monitoring in Pediatric Patients With Type 1 Diabetes
- Lead sponsor
- Copenhagen University Hospital at Herlev
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 10, 2020
- Completion date
- November 30, 2022
- Enrollment
- 236 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dermatologic complication, type 1 diabetes